IU training prog. in molecular physiology and clinical mechanisms of lung disease

IU培训计划。

• 批准号: 7694656
• 负责人: David S Wilkes
• 金额: $ 19.01万
• 依托单位: INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-05-01 至 2014-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7694656
• 关键词: Clinical; Lung diseases; Molecular; Physiology; Training

DESCRIPTION (provided by applicant): This T-32 Training application is anchored within the Indiana University School of Medicine, the principal School of the Indiana University Purdue University at Indianapolis (lUPUI). The proposed training program in Lung Immunobiology is provided by a multidisciplinary, highly collaborative group of established investigators and highly qualified and dedicated mentors. We have included in the training program classical elements of basic and clinical-translational, research, adding on developing novel technologies. These research skills will enable our trainees to accelerate the advancements in lung research and close the gaps in knowledge that prevented for so many decades the development of phenotypic characterization, effective preventive intervention, and disease- modifying or even curative druts for most patients with lung disease. Being led by Program Director who is a renowned physician scientist and experienced mentor who himself is a minority, and having direct support from an experienced Minority Advisory Board, this application demonstrates our commitment to the development of a successful training program for under-represented and minority scientists. The Program Director will obtain continuous advise and feedback regarding the operation of the Training Grant from several internal and one external committee, composed of leaders in academic medicine If funded, this program will provide the only research training program of pulmonary physicians and scientists in the state of Indiana, which has one of the highest incidence of chronic lung diseases in the country.

描述(由申请人提供)：这份T-32培训申请是在印第安纳大学医学院，印第安纳大学普渡大学印第安纳波利斯分校(LUPUI)的主要学院内提出的。拟议的肺免疫生物学培训计划由一个由知名研究人员和高资质和专注的导师组成的多学科、高度合作的小组提供。我们在培训计划中加入了基础和临床的经典元素--翻译、研究，以及开发新技术。这些研究技能将使我们的受训人员能够加快肺部研究的进步，并弥合几十年来阻碍大多数肺部疾病患者发展表型特征、有效的预防干预和疾病修改甚至治疗药物的知识差距。这份申请由著名的内科科学家和经验丰富的少数族裔导师项目主任领导，并得到经验丰富的少数族裔顾问委员会的直接支持，这表明我们致力于为代表不足和少数族裔的科学家制定成功的培训计划。项目主任将从几个由学术医学领袖组成的内部和外部委员会不断获得关于培训补助金运作的建议和反馈。如果得到资助，该计划将提供印第安纳州唯一的肺科医生和科学家研究培训计划，印第安纳州是美国慢性肺部疾病发病率最高的州之一。